Literature DB >> 32749627

The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.

Colleen B Mistler1,2, Michael M Copenhaver3,4, Roman Shrestha4,5.   

Abstract

Injection drug use is a key risk factor for the transmission of HIV. Prevention strategies, such as the use of pre-exposure prophylaxis (PrEP), are effective at reducing the risk of HIV transmission in people who inject drugs (PWID). Following PRISMA guidelines, a literature search was conducted to identify the current state of the PrEP care cascade in PWID. Twenty-three articles were evaluated in this systematic review. A decline in engagement throughout the stages of the PrEP care cascade was found. High awareness and willingness to use PrEP was found, yet PrEP uptake was relatively low (0-3%). There is a lack of research on interventions to increase engagement of PrEP across all levels of the care cascade in PWID. Implications from the interventions that have been published provide insight into practice and public policy on efficacious strategies to reduce HIV incidence in PWID. Our findings suggest that more efforts are needed to identify and screen PWID for PrEP eligibility and to link and maintain them with appropriate PrEP care.

Entities:  

Keywords:  HIV prevention; People who inject drugs (PWID); PrEP care cascade; Pre-exposure prophylaxis (PrEP); Systematic review

Mesh:

Substances:

Year:  2021        PMID: 32749627      PMCID: PMC7858689          DOI: 10.1007/s10461-020-02988-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  46 in total

1.  Comparing Canadian and United States opioid agonist therapy policies.

Authors:  Kelsey C Priest; Lauren Gorfinkel; Jan Klimas; Andrea A Jones; Nadia Fairbairn; Dennis McCarty
Journal:  Int J Drug Policy       Date:  2019-02-11

2.  Suboptimal HIV Pre-exposure Prophylaxis Awareness and Willingness to Use Among Women Who Use Drugs in the United States: A Systematic Review and Meta-analysis.

Authors:  Chen Zhang; James McMahon; Janie Simmons; L Lauren Brown; Robertson Nash; Yu Liu
Journal:  AIDS Behav       Date:  2019-10

3.  Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.

Authors:  Roman Shrestha; Pramila Karki; Frederick L Altice; Oleksandr Dubov; Liana Fraenkel; Tania Huedo-Medina; Michael Copenhaver
Journal:  AIDS Behav       Date:  2018-04

4.  Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study.

Authors:  Sean T Allen; Allison O'Rourke; Rebecca Hamilton White; Katherine C Smith; Brian Weir; Gregory M Lucas; Susan G Sherman; Suzanne M Grieb
Journal:  AIDS Behav       Date:  2020-06

5.  Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self-Report Neurocognitive Symptoms by High-Risk Drug Users: A Mediation Analysis.

Authors:  Roman Shrestha; Pramila Karki; Tania B Huedo-Medina; Michael Copenhaver
Journal:  J Assoc Nurses AIDS Care       Date:  2017-04-19       Impact factor: 1.354

6.  HIV prevalence and risk behaviors among men who have sex with men and inject drugs in San Francisco.

Authors:  Alex H Kral; Jennifer Lorvick; Daniel Ciccarone; Lynn Wenger; Lauren Gee; Alexis Martinez; Brian R Edlin
Journal:  J Urban Health       Date:  2005-02-28       Impact factor: 3.671

7.  Racial/ethnic differences in rates of depression among preretirement adults.

Authors:  Dorothy D Dunlop; Jing Song; John S Lyons; Larry M Manheim; Rowland W Chang
Journal:  Am J Public Health       Date:  2003-11       Impact factor: 9.308

8.  Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study.

Authors:  Roman Shrestha; Frederick L Altice; Pramila Karki; Michael M Copenhaver
Journal:  AIDS Behav       Date:  2018-08

9.  Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment.

Authors:  Roman Shrestha; Michael Copenhaver
Journal:  Front Public Health       Date:  2018-07-13

Review 10.  Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?

Authors:  Katherine M Rich; Joshua Bia; Frederick L Altice; Judith Feinberg
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

View more
  19 in total

1.  Examining HIV Diagnosis and Linkage to PrEP Prescription Among Members at An Integrated Health System in the Southeast United States.

Authors:  Teaniese L Davis; Mona Mittal; Adanna C Oragwu; Min Qi Wang; Bradley O Boekeloo
Journal:  AIDS Behav       Date:  2022-09-12

Review 2.  Running with Scissors: a Systematic Review of Substance Use and the Pre-exposure Prophylaxis Care Continuum Among Sexual Minority Men.

Authors:  Michael Viamonte; Delaram Ghanooni; John M Reynolds; Christian Grov; Adam W Carrico
Journal:  Curr HIV/AIDS Rep       Date:  2022-06-14       Impact factor: 5.495

Review 3.  The Potential of Telecommunication Technology to Address Racial/Ethnic Disparities in HIV PrEP Awareness, Uptake, Adherence, and Persistence in Care: A Review.

Authors:  Kimberly N Evans; Rashida Hassan; Ashley Townes; Kate Buchacz; Dawn K Smith
Journal:  AIDS Behav       Date:  2022-05-25

4.  Relationships among Substance Use, Sociodemographics, Pre-Exposure Prophylaxis (PrEP) Awareness and Related Attitudes among Young Adult Men Who Have Sex with Men.

Authors:  Nioud Mulugeta Gebru; Maria Costanza Benvenuti; Bonnie H P Rowland; Meher Kalkat; Patricia G Chauca; Robert F Leeman
Journal:  Subst Use Misuse       Date:  2022-02-21       Impact factor: 2.362

5.  Logistical Facilitators and Barriers to PrEP Implementation in Methadone Clinic Settings: Provider and Staff Perspectives.

Authors:  Jessica Jaiswal; Marybec Griffin; Kevin Hascher; Amanda B Cox; Kandyce Dunlap; Suzan Walters; Caleb LoSchiavo; Wanda M Burton; Mercy Mumba
Journal:  J Addict Med       Date:  2022-02-14       Impact factor: 4.647

6.  Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment.

Authors:  Zhao Ni; Frederick L Altice; Jeffrey A Wickersham; Michael M Copenhaver; Elizabeth E DiDomizio; LaRon E Nelson; Roman Shrestha
Journal:  Drug Alcohol Depend       Date:  2021-01-07       Impact factor: 4.492

7.  Reaching Those Most at Risk for HIV Acquisition: Evaluating Racial/Ethnic Disparities in the Preexposure Prophylaxis Care Continuum in Baltimore City, Maryland.

Authors:  Christina M Schumacher; Xueting Tao; Aruna Chandran; Errol Fields; Ashley Price; Adena Greenbaum; Jacky M Jennings
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-15       Impact factor: 3.771

8.  Delivering Preexposure Prophylaxis to People Who Use Drugs and Experience Homelessness, Boston, MA, 2018-2020.

Authors:  Katie B Biello; Angela R Bazzi; Seamus Vahey; Mary Harris; Leah Shaw; Jennifer Brody
Journal:  Am J Public Health       Date:  2021-06       Impact factor: 11.561

9.  Mobile low-threshold buprenorphine integrated with infectious disease services.

Authors:  Amanda Rosecrans; Robert Harris; Ronald E Saxton; Margaret Cotterell; Meredith Zoltick; Catherine Willman; Ingrid Blackwell; Joy Bell; Darryl Hayes; Brian Weir; Susan Sherman; Gregory M Lucas; Adena Greenbaum; Kathleen R Page
Journal:  J Subst Abuse Treat       Date:  2021-06-24

10.  Integrating HIV Preexposure Prophylaxis With Community-Based Syringe Services for Women Who Inject Drugs: Results From the Project SHE Demonstration Study.

Authors:  Alexis M Roth; Nguyen K Tran; Marisa Felsher; Annette B Gadegbeku; Brogan Piecara; Rachel Fox; Douglas S Krakower; Scarlett L Bellamy; K Rivet Amico; Jose A Benitez; Barbara Van Der Pol
Journal:  J Acquir Immune Defic Syndr       Date:  2021-03-01       Impact factor: 3.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.